TruNativ Raises $30 Million in Series B Round
Mumbai-based TruNativ, a leading Indian nutrition brand known for its 100% natural products, has successfully raised $30 million in its Series B funding round. The round was led by OrbiMed, a prominent investor in the healthcare sector. Other participants in this round included 100Unicorns, Rainmatter, and Venture Catalysts.
Company Background
TruNativ, founded by Pranav Malhotra, who also serves as the CEO, offers a variety of natural nutrition products aimed at promoting healthier lifestyles. The company has gained popularity in India for its commitment to providing high-quality, natural nutrition solutions.
Use of Funds
The newly acquired funds will primarily be used to bolster TruNativ's offline distribution network. This strategic move aims to expand their market reach and make their products more accessible to consumers across different regions. By strengthening its offline presence, TruNativ plans to tap into new customer segments and enhance its brand visibility in the competitive nutrition market.
Strategic Partnerships and Future Plans
The involvement of investors like 100Unicorns, Rainmatter, and Venture Catalysts indicates a strong belief in TruNativ's growth potential and market strategy. With OrbiMed leading the investment, TruNativ is well-positioned to leverage expertise and resources to further its business objectives.
This funding round marks a significant milestone for TruNativ as it continues to expand its footprint in the nutrition sector. The company remains focused on delivering high-quality, natural products while scaling its operations to meet the growing demand in India.